Florida Schedule 2 Prescriptions: E-Prescribing, 3-Day Cap, PDMP

Florida’s Schedule II prescription rules require that every prescription be electronic or written (never phoned in except in a 72-hour emergency), that it carry no refills, that the prescriber check the state monitoring database before issuing it, and that opioid prescriptions for acute pain be capped at three days unless a documented exception applies. Federal DEA rules sit on top of the state framework, and both sets of rules carry real consequences when ignored.

What Has to Appear on the Prescription

A Schedule II prescription in Florida must include the patient’s full name and address, the prescriber’s full name, address, and DEA registration number, the drug name, strength, quantity, and directions for use. The quantity has to be written out and given as a number. The prescription must be dated and signed on the day it is issued.¹

Paper prescriptions have to be written on a standardized counterfeit-proof pad produced by a department-approved vendor. Electronic prescriptions carry the same required elements plus an electronic signature entered on the date of issuance.¹ Oral prescriptions are only for emergencies and are limited to a 72-hour supply. Pharmacies hold filled Schedule II prescriptions on file for at least two years.²

Electronic Prescribing Is the Default

Since July 2021, Florida has required prescribers to transmit prescriptions electronically, including controlled substances. The mandate took effect on license renewal or by the July 2021 deadline, whichever came first.³

Paper or another alternative remains permissible in specific cases:

The prescriber and the dispenser are the same person.
The drug cannot be transmitted electronically under the current NCPDP SCRIPT Standard.
The practitioner has a department hardship waiver (up to one year) for economic reasons or technology limitations outside their control.
Electronic transmission would delay treatment and harm the patient.
The prescription is part of an active research study.
The drug’s FDA prescribing requirements include elements that cannot be captured electronically.
The prescription is for a hospice patient or a nursing facility resident.
The practitioner or patient decides that comparing prices across pharmacies is in the patient’s best interest, documented in the medical record.

Medicare Part D prescriptions for Schedule II through V substances are also subject to a federal electronic transmission requirement, with similar carve-outs.³

No Refills, but Up to Three Prescriptions at One Visit

Schedule II prescriptions cannot be refilled under either federal law or Florida statute.⁴² Every additional supply requires a new prescription.

Federal regulation does allow one workaround. At a single office visit, a prescriber can issue up to three separate prescriptions covering up to a 90-day total supply. Each prescription after the first must carry the earliest date the pharmacy may fill it. The prescriber must find that issuing multiple prescriptions does not create an undue risk of diversion or abuse, and the practice must be permitted under Florida law.⁴

Three-Day Cap for Acute Pain Opioids

A Schedule II opioid prescribed for acute pain in Florida is limited to a three-day supply. A seven-day supply is possible only if all three of these are true:

The prescriber’s professional judgment supports that more than three days is medically necessary for the acute condition.
The prescription is marked “ACUTE PAIN EXCEPTION.”
The medical record documents the acute condition and explains why alternative treatments are insufficient.

The cap applies to Schedule II opioids. Chronic pain prescribing runs on a different track.⁵

Chronic Nonmalignant Pain: Extra Documentation

Prescribing Schedule II drugs for chronic nonmalignant pain adds duties under Florida Statute 456.44. Before treatment starts, the prescriber must complete a full medical history and physical examination, documented in the record. That documentation has to cover the nature and intensity of the pain, current and past treatments, coexisting conditions, the effect of pain on physical and psychological function, a review of prior medical records and diagnostic studies, and a history of alcohol and substance use.⁵

A written individualized treatment plan is required, stating measurable objectives such as pain relief and improved function, and indicating whether further evaluations or alternative treatments are planned. Drug therapy has to be adjusted to the patient’s individual needs over time. When other modalities such as rehabilitation are folded in, the record must reflect that interdisciplinary approach.⁵

The prescriber must also develop a written plan for assessing the patient’s risk of aberrant drug-related behavior, which may include drug testing, and must monitor that risk on an ongoing basis. Before starting therapy, the prescriber has to discuss the risks and benefits of controlled substance use with the patient (or the patient’s guardian or designated representative), covering abuse, addiction, and physical dependence. That conversation is backed by a written controlled substance agreement outlining the patient’s responsibilities during treatment.⁵

Check the PDMP Before Prescribing

Florida’s Prescription Drug Monitoring Program, E-FORCSE, is established under Florida Statute 893.055. Before prescribing or dispensing a controlled substance to any patient aged 16 or older, the prescriber must consult the database. The only exceptions are nonopioid Schedule V drugs and patients admitted to hospice.⁶

A first-time failure to consult triggers a nondisciplinary citation. Subsequent violations can move into formal discipline. The database itself logs whether a query was made, so a missed check leaves its own record. Prescribers and their designees have direct access to a patient’s dispensing history in the system.⁷

When a Prescriber Can Dispense Schedule II Directly

Practitioners who dispense medications to patients for a fee must register with their professional licensing board as a dispensing practitioner and pay a registration fee of up to $100 at registration and each renewal.⁸ Handing out complimentary drug samples at no charge to one’s own patients in the regular course of practice does not require registration.

Registered dispensing practitioners generally cannot dispense Schedule II or Schedule III controlled substances. The exceptions are narrow:

Complimentary drug samples given at no charge to the practitioner’s own patients.
Substances dispensed within the Department of Corrections health care system.
Dispensing in connection with a surgical procedure.
Dispensing as part of an approved clinical trial.
Methadone dispensed at a licensed medication-assisted treatment facility.
Dispensing to patients of a facility licensed under Part IV of Chapter 400.
FDA-approved medications for treating opioid addiction, dispensed by a practitioner authorized under federal law.

Outside those exceptions, a Schedule II prescription has to be filled at a pharmacy. Before dispensing any drug, the practitioner must give the patient a written prescription and advise (orally or in writing) that it may be filled in the office or at any pharmacy of the patient’s choice. Records of controlled substance prescriptions dispensed must be maintained for four years.⁸⁹

DEA Registration and Form 222

Before prescribing any Schedule II through V controlled substance, a practitioner must hold an active DEA registration. The registration certificate is valid for 36 months and is renewed using DEA Form 224a.¹⁰

Ordering Schedule II inventory is a separate exercise. Each distribution has to be documented on a DEA Form 222, with only one item per numbered line and a limit of 20 line items per form (additional forms may be used for larger orders). The form can be signed by the registrant or by someone holding a valid power of attorney signed by the registrant, the authorized person, and two witnesses.¹¹

Storage, Theft, and Loss

Federal regulations require Schedule II controlled substances to be stored in a securely locked, substantially constructed cabinet. Pharmacies and institutional practitioners have an alternative of dispersing controlled substances throughout their noncontrolled stock in a way designed to obstruct theft or diversion. Certain high-potency substances such as carfentanil and etorphine must be stored in a safe or steel cabinet equivalent to a U.S. Government Class V security container.¹²

If controlled substances are stolen or go missing, the registrant must notify the local DEA Division Field Office in writing within one business day of discovery. An email to the appropriate regional contact meets the “in writing” requirement. Within 45 days of discovery, the registrant must file a complete DEA Form 106 (Report of Theft or Loss of Controlled Substances) online.¹³

Lost or stolen Form 222 order forms trigger their own reporting duty: immediate notification to the local DEA Diversion Field Office with the serial numbers of the missing forms, and execution of a replacement form with a statement explaining the situation.¹¹

What Happens If You Get It Wrong

A practitioner who provides a Schedule II controlled substance (or a prescription for one) that is not medically necessary, or that is obtained through fraud, misrepresentation, or concealment of a material fact, commits a second-degree felony. Separate provisions target prescribers who use tricks or schemes to help patients obtain controlled substances, write prescriptions for fictitious patients, or write prescriptions solely to generate a monetary benefit. Those acts are third-degree felonies, but the charge becomes a second-degree felony if the prescriber received $1,000 or more in payment for the fraudulent prescriptions.¹⁴

Administratively, a first failure to consult the PDMP brings a nondisciplinary citation; later violations can lead to formal disciplinary proceedings.⁶ Licensing boards can impose fines, order additional education, restrict prescribing privileges, or revoke a practitioner’s license. The DEA can suspend or revoke a registration independently of any state action, which shuts off controlled substance prescribing entirely.

1
Florida Senate. Florida Statutes 456.42 – Written Prescriptions for Medicinal Drugs
2
Online Sunshine. Florida Statutes 893.04 – Pharmacist and Practitioner
3
Florida Board of Pharmacy. Electronic Prescribing Requirements
4
eCFR. 21 CFR 1306.12 – Refilling Prescriptions; Issuance of Multiple Prescriptions
5
Online Sunshine. Florida Statutes 456.44 – Controlled Substance Prescribing
6
Online Sunshine. Florida Statutes 893.055 – Prescription Drug Monitoring Program
7
Florida Department of Health. Information for Health Care Practitioners
8
Online Sunshine. Florida Statutes 465.0276 – Dispensing Practitioner
9
Florida Department of Health. Dispensing Practitioners Inspection Form
10
U.S. Drug Enforcement Administration. Practitioner’s Manual
11
U.S. Drug Enforcement Administration. DEA Form 222 Q&A
12
eCFR. 21 CFR 1301.75 – Physical Security Controls for Practitioners
13
U.S. Drug Enforcement Administration. Reporting the Theft and Loss of Controlled Substances
14
Online Sunshine. Florida Statutes 893.13 – Prohibited Acts; Penalties